Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines.

Benson AB 3rd, Arnoletti JP, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Engstrom PF, Enzinger PC, Fakih MG, Fleshman JW Jr, Fuchs CS, Grem JL, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W Jr, Sofocleous CT, Venook AP, Willett C, Freedman-Cass DA; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2012 Apr;10(4):449-54.

PMID:
22491045
2.

Role of positron emission tomography-computed tomography in the management of anal cancer.

Mistrangelo M, Pelosi E, Bellò M, Ricardi U, Milanesi E, Cassoni P, Baccega M, Filippini C, Racca P, Lesca A, Munoz FH, Fora G, Skanjeti A, Cravero F, Morino M.

Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):66-72. doi: 10.1016/j.ijrobp.2011.10.048. Epub 2012 May 15.

3.

Anal carcinoma: FDG PET/CT in staging, response evaluation, and follow-up.

Saboo SS, Zukotynski K, Shinagare AB, Krajewski KM, Ramaiya N.

Abdom Imaging. 2013 Aug;38(4):728-35. doi: 10.1007/s00261-012-9958-3. Review.

PMID:
23011550
4.

Positron emission tomography/computed tomography in the staging and treatment of anal cancer.

Sveistrup J, Loft A, Berthelsen AK, Henriksen BM, Nielsen MB, Engelholm SA.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):134-41. doi: 10.1016/j.ijrobp.2011.06.1955. Epub 2011 Oct 12.

PMID:
22000745
5.

F-18 FDG PET/CT imaging of anal canal squamous cell carcinoma.

Nguyen BD, Ram PC, Roarke MC.

Clin Nucl Med. 2007 Mar;32(3):234-6. No abstract available.

PMID:
17314608
6.

Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome.

Milano MT, Jani AB, Farrey KJ, Rash C, Heimann R, Chmura SJ.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):354-61.

PMID:
16168830
7.
8.

Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.

Bannas P, Weber C, Adam G, Frenzel T, Derlin T, Mester J, Klutmann S.

Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):445-51. doi: 10.1016/j.ijrobp.2010.05.050. Epub 2010 Sep 9.

PMID:
20832181
9.

FDG-PET/CT: new horizons in anal cancer.

Grigsby PW.

Gastroenterol Clin Biol. 2009 May;33(5):456-8. doi: 10.1016/j.gcb.2009.01.012. Epub 2009 Apr 24.

10.

Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.

Tempero MA, Arnoletti JP, Behrman SW, Ben-Josef E, Benson AB 3rd, Casper ES, Cohen SJ, Czito B, Ellenhorn JD, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Ma WW, Malafa MP, Merchant NB, Mulvihill SJ, Muscarella P 2nd, Nakakura EK, Obando J, Pitman MB, Sasson AR, Tally A, Thayer SP, Whiting S, Wolff RA, Wolpin BM, Freedman-Cass DA, Shead DA; National Comprehensive Cancer Networks.

J Natl Compr Canc Netw. 2012 Jun 1;10(6):703-13.

11.

Assessing the impact of FDG-PET in the management of anal cancer.

Nguyen BT, Joon DL, Khoo V, Quong G, Chao M, Wada M, Joon ML, See A, Feigen M, Rykers K, Kai C, Zupan E, Scott A.

Radiother Oncol. 2008 Jun;87(3):376-82. doi: 10.1016/j.radonc.2008.04.003. Epub 2008 Apr 29.

PMID:
18453023
12.

Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer.

Mistrangelo M, Pelosi E, Bellò M, Castellano I, Cassoni P, Ricardi U, Munoz F, Racca P, Contu V, Beltramo G, Morino M, Mussa A.

Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):73-8. doi: 10.1016/j.ijrobp.2009.04.020. Epub 2009 Jul 23.

PMID:
19632066
13.

FDG PET/CT in the management of colorectal and anal cancers.

Agarwal A, Marcus C, Xiao J, Nene P, Kachnic LA, Subramaniam RM.

AJR Am J Roentgenol. 2014 Nov;203(5):1109-19. doi: 10.2214/AJR.13.12256. Review.

PMID:
25341152
14.

The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer.

Winton Ed, Heriot AG, Ng M, Hicks RJ, Hogg A, Milner A, Leong T, Fay M, MacKay J, Drummond E, Ngan SY.

Br J Cancer. 2009 Mar 10;100(5):693-700. doi: 10.1038/sj.bjc.6604897.

15.

Assessment of target dose delivery in anal cancer using in vivo thermoluminescent dosimetry.

Weber DC, Nouet P, Kurtz JM, Allal AS.

Radiother Oncol. 2001 Apr;59(1):39-43.

PMID:
11295204
16.

PET/CT in anal cancer - is it worth doing?

Wells IT, Fox BM.

Clin Radiol. 2012 Jun;67(6):535-40. doi: 10.1016/j.crad.2011.10.030. Epub 2011 Dec 29.

PMID:
22208962
17.

Post burn Marjolin's ulcer in the natal cleft mimicking anal canal carcinoma: a rare site.

Jain SK, Tanwar R, Kaza RC, Ghuliani D.

J Wound Care. 2010 Dec;19(12):532-4.

PMID:
21160444
18.

Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer.

Ng M, Leong T, Chander S, Chu J, Kneebone A, Carroll S, Wiltshire K, Ngan S, Kachnic L.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1455-62. doi: 10.1016/j.ijrobp.2011.12.058. Epub 2012 Mar 6.

PMID:
22401917
19.

Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines.

Mohler JL, Armstrong AJ, Bahnson RR, Boston B, Busby JE, D'Amico AV, Eastham JA, Enke CA, Farrington T, Higano CS, Horwitz EM, Kantoff PW, Kawachi MH, Kuettel M, Lee RJ, MacVicar GR, Malcolm AW, Miller D, Plimack ER, Pow-Sang JM, Roach M 3rd, Rohren E, Rosenfeld S, Srinivas S, Strope SA, Tward J, Twardowski P, Walsh PC, Ho M, Shead DA.

J Natl Compr Canc Netw. 2012 Sep;10(9):1081-7.

PMID:
22956807
20.

Impact of PET/CT on initial staging, restaging and treatment management of anal cancer: a clinical case with literature review.

Piperkova E, Raphael B, Altinyay M, Castellon I, Libes R, Sandella N, Abdel-Dayem H.

J BUON. 2006 Oct-Dec;11(4):523-7.

PMID:
17309188

Supplemental Content

Support Center